Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC)

<div>Kaplan–Meier curves for disease-free and overall survival demonstrating median survival of 35.3 months (95% CI: 27.6–43.0) and a 1-, 5-, and 10-year overall survival of 86.2%, 64.3%, and 58.7%, respectively, with associated number at risk for each time point.</div>

Sarcoma

fig2

Figure 2

Figure 2: Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC) 

Figure 2 | Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC) 